National Research Co. (NASDAQ:NRC) Stock Position Lifted by Renaissance Technologies LLC

Renaissance Technologies LLC boosted its stake in National Research Co. (NASDAQ:NRC) by 14.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 432,884 shares of the company’s stock after buying an additional 54,600 shares during the quarter. Renaissance Technologies LLC owned approximately 1.81% of National Research worth $9,935,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the stock. Benjamin F. Edwards & Company Inc. raised its position in National Research by 860.2% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock valued at $45,000 after acquiring an additional 1,015 shares in the last quarter. CWM LLC raised its holdings in shares of National Research by 889.7% during the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after purchasing an additional 1,041 shares in the last quarter. SYSTM Wealth Solutions LLC acquired a new stake in shares of National Research in the 1st quarter valued at $170,000. Principal Financial Group Inc. bought a new stake in National Research in the first quarter worth $221,000. Finally, Precision Wealth Strategies LLC increased its position in National Research by 7.9% during the first quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock worth $223,000 after buying an additional 413 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Price Performance

Shares of NASDAQ:NRC opened at $22.00 on Tuesday. The stock has a market capitalization of $525.29 million, a P/E ratio of 17.74 and a beta of 0.48. The business has a 50-day moving average of $22.56 and a two-hundred day moving average of $28.28. National Research Co. has a fifty-two week low of $20.41 and a fifty-two week high of $47.08. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.37 and a quick ratio of 0.37.

National Research (NASDAQ:NRC) last posted its earnings results on Tuesday, August 6th. The company reported $0.26 earnings per share for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The firm had revenue of $35.02 million during the quarter.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be paid a $0.12 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.18%. National Research’s payout ratio is presently 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.